Infection

Papers
(The H4-Index of Infection is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Emergence of Campylobacter fetus bacteraemias in the last decade, France244
Investigation of the pathogen-specific antibody response in periprosthetic joint infection120
Reply to: Differential diagnosis between Kaposi sarcoma-associated herpesvirus cytokine syndrome and hemophagocytic lymphohistiocytosis116
Reply to: Challenges in interpreting the role of gentamicin in treatment of invasive listeriosis: immortal timebias and confounding114
High risk of drug-resistant tuberculosis in IGRA-negative contacts: should preventive treatment be considered?103
Analytical performance of the point-of-care BIOSYNEX COVID-19 Ag BSS for the detection of SARS‐CoV‐2 nucleocapsid protein in nasopharyngeal swabs: a prospective field evaluation during the COVID-19 th91
Diagnostic delay in pulmonary blastomycosis: a case series reflecting a referral center experience88
No link between the prevalence of hepatitis E virus infection and the diagnosis of schizophrenia84
Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel64
Preadmission course and management of severe pediatric group A streptococcal infections during the 2022–2023 outbreak: a single-center experience60
Diagnosis and management of complicated urogenital schistosomiasis: a systematic review of the literature58
Diagnostic nomogram to differentiate between epididymal tuberculosis and bacterial epididymitis55
Rare and risky: a unique case of concurrent chronic pulmonary aspergillosis and lemierre syndrome53
Household transmission of Omicron variant of SARS-CoV-2 under conditions of hybrid immunity—a prospective study in Germany53
Outcome of Human Parainfluenza Virus infection in allogeneic stem cell transplantation recipients: possible impact of ribavirin therapy51
Towards shortening the duration of antibiotic therapy for Lyme borreliosis: a systematic review and meta-analysis49
Differential efficacy and safety of anti-SARS-CoV-2 antibody therapies for the management of COVID-19: a systematic review and network meta-analysis48
Point-of-care ultrasound to assess volume status and pulmonary oedema in malaria patients46
Epidemiology and risk factors of community-acquired pneumonia in patients with different causes of immunosuppression46
Clinical and microbiological characteristics of polymicrobial bacteremia: a retrospective, multicenter study44
Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis41
Risk of hemolysis in Plasmodium vivax malaria patients receiving standard primaquine treatment in a population with high prevalence of G6PD deficiency41
Emergence and characterization of mixed Candida auris strain infections in China41
SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies39
Association of stress hyperglycemia ratio and mortality in patients with sepsis: results from 13,199 patients39
Blazing the trail for innovative tuberculosis diagnostics38
Experience with dalbavancin use in various gram-positive infections within Aberdeen Royal Infirmary OPAT service37
Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 and BA.5 subvariant predominance: a systematic literature review34
Correction: A simple scoring algorithm predicting paravertebral and/or Iliopsoas abscess among adults with community-onset bloodstream infections: matters of PVL-producing staphylococcus aureus33
The relationship between group A streptococcus test positivity and clinical findings in tonsillopharyngitis in children: systematic review and meta-analysis33
SARS-CoV-2 infection in technology-dependent children: a multicenter case series33
Klebsiella pneumoniae species complex bloodstream infection in adult patients: changing epidemiology and determinants of poor outcomes33
High titer of antibody against the SARS-CoV-2 spike protein among patients receiving neutralizing antibody cocktail therapy with REGN-COV32
0.33932685852051